Dose Insider / Glossary / MTC

Medullary thyroid carcinoma (MTC)The cancer behind the GLP-1 boxed warning

Updated November 20, 2026 · 3 min read · Wegovy, Saxenda and Foundayo labels; MedlinePlus; Pasternak 2024; Bezin 2023

Medullary thyroid carcinoma, or MTC, is a cancer of the thyroid gland that starts in the C cells, the cells that release the hormone calcitonin. It is very rare.1 MTC is named in the boxed warning at the top of the labels of GLP-1 medicines such as Wegovy, Saxenda and Foundayo.

1.19Scandinavia, 2024, MTC, thyroid cancer risk ratios
Thyroid cancer risk ratiosHazard ratio vs other diabetes drugsSCANDINAVIA, 2024All thyroid cancer0.93MTC1.19FRANCE, 1 TO 3 YEARS OF USEAll thyroid cancer1.58MTC1.78Thyroid cancer risk ratiosHazard ratio vs other diabetes drugsSCANDINAVIA, 2024All thyroid cancer0.93MTC1.19FRANCE, 1 TO 3 YEARS OF USEAll thyroid cancer1.58MTC1.78

Above 1 means more cases; the MTC ranges were wide.

On this page

The warning comes from thyroid C-cell tumors in rats and mice; whether the drugs cause MTC in people has not been determined.2

What MTC is

MedlinePlus describes two forms. Sporadic MTC does not run in families; most cases are sporadic, and this form mainly affects older adults. Hereditary MTC runs in families, and the risk is higher with a family history of MTC or of multiple endocrine neoplasia, MEN.1 It often begins as a small lump, or nodule, in the thyroid, sometimes with swollen lymph nodes in the neck. Symptoms can include swelling of the neck, hoarseness, breathing problems, cough, coughing up blood, and diarrhea caused by high calcitonin. Treatment is surgery to remove the thyroid and nearby lymph nodes. MedlinePlus puts 10-year survival at 65%.1

What the warning says

Wegovy label, boxed warning.2

The Saxenda label for liraglutide carries the same warning.3 The Foundayo label for orforglipron, a small molecule, adds a twist: orforglipron is not active at the GLP-1 receptor of rats or mice and did not produce tumors in them. The label keeps the warning anyway, because the drug does act on the human receptor and the tumors seen with other drugs of the class are considered effects of that receptor.4

Why routine tests are not advised

The Wegovy label says routine monitoring of calcitonin or thyroid ultrasound is of uncertain value for finding MTC early in people on the drug. Such monitoring may lead to unnecessary procedures, because the calcitonin test is not specific and thyroid disease is common in the population. People with MTC usually have calcitonin above 50 ng/L, and a high result, or a nodule found on exam or imaging, should be evaluated further.2

What human studies show

Two large studies of people with type 2 diabetes reached different answers. They are reported as hazard ratios, where 1.0 means no difference from the comparison drug.

The Scandinavian authors concluded that GLP-1 use was not associated with a substantially increased risk over the mean follow-up. Neither study changes the label: the warning and the contraindications stand.

Sources

  1. MedlinePlus. Thyroid cancer - medullary carcinoma. A.D.A.M. Medical Encyclopedia; review date January 29, 2026, read November 20, 2026. medlineplus.gov
  2. WEGOVY (semaglutide) injection prescribing information. Novo Nordisk; DailyMed, version 19, published June 30, 2026; boxed warning and section 5.1. dailymed.nlm.nih.gov
  3. SAXENDA (liraglutide) injection prescribing information. Novo Nordisk; DailyMed, version 22, published June 15, 2026; boxed warning. dailymed.nlm.nih.gov
  4. FOUNDAYO (orforglipron) tablets prescribing information. Eli Lilly; DailyMed, version 10, published August 13, 2026; boxed warning. dailymed.nlm.nih.gov
  5. Pasternak B, Wintzell V, Hviid A, et al. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. BMJ 2024;385:e078225. doi:10.1136/bmj-2023-078225
  6. Bezin J, Gouverneur A, Pénichon M, et al. GLP-1 receptor agonists and the risk of thyroid cancer. Diabetes Care 2023;46:384-390. doi:10.2337/dc22-1148

Related analyses

Log any neck lump, hoarseness or trouble swallowing with the date, and show your doctor.

Open Dose Insider